Mediclinic International reports robust half year

  • Thu 14 Nov 2019 07:59

    In its results for the six months ended 30 September 2019, Mediclinic International announced a 9% growth in revenue.

    The company also declared an interim dividend maintained at 3.20p per share.

    Adjusted EBITDA was up 4% at £222m, while adjusted earnings per share were flat at 10.3p.

    According to the half year report, adjusted operating profit remained flat at £137m, reflecting increased depreciation charges associated with infrastructure and technology investments.

    Reported operating profit rose 264% to £142m, reflecting prior year period non-cash Hirslanden impairment charges of £98m

<< Back <<

Mediclinic International (MDC)

403.80p +8.50p (+2.15%) delayed 18:45PM
Price delayed by 15 minutes.